PedAM
Pediatric Disease Annotations & Medicines
| Disease | prostate cancer |
| Phenotype | C0007222|cardiovascular disease |
| Sentences | 9 |
| PubMedID- 19996060 | We evaluated the relationship between androgen deprivation therapy and incident diabetes and cardiovascular disease in men of all ages with prostate cancer. |
| PubMedID- 21319864 | Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with prostate cancer. |
| PubMedID- 20567006 | Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the population-based pcbase sweden. |
| PubMedID- 26163614 | Conclusions: application of endocrinotherapy in prostate cancer can easily lead to occurrence of cardiovascular disease, but cardiovascular complications can be prevented by aspirin, without affecting the effect of endocrinotherapy. |
| PubMedID- 21448299 | Adt should not be unnecessarily administered to prostate cancer patients with pre-existing cardiovascular disease, and certainly not to those in whom the risk of prostate cancer-specific mortality is low. |
| PubMedID- 25451829 | Androgen deprivation therapy was not associated with an increased risk of diabetes or cardiovascular disease in men diagnosed with prostate cancer before age 70 years. |
| PubMedID- 20310055 | Conclusions: elderly men who had high-risk prostate cancer without cardiovascular disease or with surgically corrected cardiovascular disease had a lower risk of pcsm when they received cmt than when they received brachytherapy alone. |
| PubMedID- 25598932 | [42] conducted a meta-analysis on randomized controlled trials (rcts) to investigate the correlation between adt and cardiovascular disease in patients with prostate cancer. |
| PubMedID- 24318956 | Is digoxin use for cardiovascular disease associated with risk of prostate cancer. |
Page: 1